$LEU

UBS raises Centrus Energy stock price target on higher margins

UBS raised its price target for Centrus Energy (LEU) to $185 from $170, citing higher margins and revised EBITDA estimates. The stock trades at $175.06, above its Fair Value. Centrus reported Q2 2026 EPS of $0.77, beating expectations, and raised its backlog to $4.5 billion. UBS maintains a Neutral rating, while Barclays initiated coverage with an Equalweight rating and $207 target.

Original reporting
Published Aug 19, 2026, 2:27 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 19, 2026, 7:45 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefEarnings
Primary signal
$LEU
Bullish
high confidence
Mentioned
$LEU
Relevance
7/10
alphai data visualization · based on investing.com
Decision brief

The 30-second read

$LEUBullishMed
01

Why it matters

UBS's upgrade could attract short‑term buying, but long‑term execution risk remains.

02

Market read

Analyst upgrade and earnings beat provide a fresh catalyst for LEU.

03

What to watch

Potential regulatory or supply‑chain constraints on HALEU contracts.

Relevance 7/10Novelty 7/10Timing: post-market

Background

Wall Street higher on falling yields; Fed minutes hint at future rate hikes.

Company-level read

Ticker impact

$LEUBullishHigh confidence
Context

UBS raised its price target on Centrus Energy to $185 and reported Q2 2026 earnings beat and higher EBITDA estimates.

Expected impact

Potential short-term price rally toward the new target.

Evidence & confidence

The price target increase and earnings beat are fresh information that can move the stock.

Market effects

Positive for nuclear fuel sector as higher margins signal industry strength.

Limited to US energy and nuclear markets.

Modest, reflects broader interest in advanced nuclear fuel.

Counterpoint

The higher target may be premature given long‑dated enrichment capacity build‑out risks.

Key entities

  • Centrus Energy Corp.

    Nuclear fuel producer (ticker LEU).

  • UBS

    Raised price target and provided earnings commentary.

Related articles

$LEUHighAI 9/10

LEU Stock Rallies As HALEU Backlog And Guidance Jump

Centrus Energy Corp. (LEU) stock rose 9.17% on August 25, 2026, following strong Q2 results. The company reported $176.1M in revenue, up 14% YoY, and adjusted net income of $38.7M. LEU's backlog reached $4.5B, supported by a $900M DOE contract and an X-energy deal. Analysts have mixed views on valuation, with targets ranging from $207 to $337.

$LEUHighAI 8/10

LEU Stock Powers Higher On HALEU Deals And Earnings Beat

Centrus Energy Corp. (LEU) stock rose 9.17% after reporting Q2 2026 revenue of $176.1M, up 14% YoY, and adjusted EPS of $1.77, beating estimates. The company secured a $900M HALEU deal with the DOE and a contract with X-energy, boosting its backlog to $4.5B. Analysts have mixed price targets, with a consensus around $252-254.

$NBISMed

3 Growth Stocks to Buy Before Wall Street Catches On

Nebius (NBIS) reported 454% revenue growth and a $37.5B backlog, with Meta and NVIDIA deals. Symbotic (SYM) trades near 52-week lows despite a $22.5B backlog. Centrus Energy (LEU) beat Q2 EPS by 93% with a $4.5B backlog. All three companies show high growth but trade below consensus targets.

$LEUMed

Centrus Energy to make thousands of centrifuges in Oak Ridge | Exclusive

Centrus Energy says its Oak Ridge plant will ramp production of AC100M uranium enrichment centrifuges over the next three years, supporting HALEU output at its Piketon, Ohio facility. The company cites a $900 million DOE task order and a 16-centrifuge demo cascade. Centrus and Oklo plan HALEU deliveries starting 2029 for Oklo’s Aurora reactors.